Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tibetan medicine advanced over past decade 2023-04-24 17:04
Samsung Biologics Reports First Quarter 2023 Financial Results 2023-04-24 14:51
Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform 2023-04-24 08:00
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer 2023-04-21 09:06
CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer 2023-04-20 20:50
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics 2023-04-20 20:30
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
500 women join Australia's landmark maternity medical device study 2023-04-19 21:08
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability 2023-04-19 21:00
China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering 2023-04-19 20:30
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use 2023-04-19 11:05
AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting 2023-04-19 08:29
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting 2023-04-19 07:00
Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial 2023-04-18 21:00
GC Genome to Present the Brand New Liquid Biopsy Platform for Cancer Detection at AACR Annual Meeting 2023 2023-04-18 13:36
GC Biopharma celebrates 'World Hemophilia Day' 2023-04-18 09:03
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023 2023-04-18 08:00
Promising Efficacy of AT101 CAR-T for Blood Cancer 2023-04-18 02:00
Asieris Releases 2022 Annual Report: Makes Steady Progress in its Clinical Development, Global Expansion to Treat Genitourinary Tumors, and Implementing its Commercialization Strategy to Provide Integrated Diagnosis-to-Treatment Solutions 2023-04-17 18:30
Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development 2023-04-17 16:50
1 52 53 54 55 56 165